Gastroenterologia Japonica

, Volume 28, Supplement 4, pp 120–127 | Cite as

Present status of fulminant hepatitis in Japan (1989–1991)

  • Yasutoshi Muto
Selected up-to-date summaries of the research group of intractable hepatitis, the ministry of health and welfare of japan (1989–1991)


To improve the survival of patients with FH, its distinct clinical subtypes should be defined and predicted at an early stage. In addition to providing clinical care for FH patients in an intensive care unit, new specific and intelligent treatments must be developed through basic research which focuses on finding a means of inducing the necrotic liver to regenerate. In any event, the Research Subgroup of FH seems to be unique in its ability to exchange information and collaborate to realize eradication of this fatal disorder.


Fulminant Hepatic Failure Fulminant Hepatitis Hepatic Coma Artificial Liver Support Massive Hepatic Necrosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    The proceedings of the 12th Inuyama Symposium. Hepatitis Type A-Fulminant Hepatitis. Tokyo: Chugai Igaku-sha, 1982;110–230. (in Japanese)Google Scholar
  2. 2.
    Trey C. The fulminant hepatic failure surveillance study. Brief review of the effects of presumed etiology and age on survival. Can Med Assoc J 1972;106:525–527.PubMedGoogle Scholar
  3. 3.
    Takahashi Y. Acute hepatic failure—In special relation to treatment. Jpn J Med 1983;22:140–145.PubMedGoogle Scholar
  4. 4.
    Matsushita H. A study on the corrected incidences of fulminant hepatitis, acute hepatitis, chronic hepatitis, liver cirrhosis and hepatoma in Japan. The 1975 Annual Report of Research Group of Intractable Hepatitis, The Ministry of Health and Welfare of Japan. 1975;23-28. (in Japanese)Google Scholar
  5. 5.
    Takahashi Y, Shimizu M, The Study Group of Fulminant Hepatitis. Aetiology and prognosis of fulminant viral hepatitis in Japan: A multicenter study. J Gastroenterol Hepatol 1991;6:159–164.PubMedGoogle Scholar
  6. 6.
    Gimson AES, O’Grady J, Ede R, et al. Late onset hepatic failure: Clinical, serological and histological features. Hepatology 1986; 6:288–294.PubMedCrossRefGoogle Scholar
  7. 7.
    Kumahara T, Muto Y, Moriwaki H, et al. Determination of the integrated CT number of the whole liver in patients with severe hepatitis: as an indicator of the functional reserve of the liver. Gastroenterol Jpn 1989;24:290–297.PubMedGoogle Scholar
  8. 8.
    A Comprehensive Research Project A, The Ministry of Education, Science and Culture of Japan. Basic studies on underlying mechanisms of the development of fulminant hepatitis (Chief investigator: Y. Muto, No. 01304038, 1989–1991) (in Japanese).Google Scholar
  9. 9.
    Tsutsui H, Mizoguchi Y, Yamamoto S, et al. Studies on experimentally-induced acute hepatic failure: Possible involvement of activated liver adherent cells. Cells of hepatic sinusoid. ed. Kirn A, Knook DL, Wisse E. The Kuppfer Cell Foundation, Netherland. 1986;307–314.Google Scholar
  10. 10.
    Mochida S, Ogata I, Hirata K, et al. Provocation of massive hepatic necrosis by endotoxin after partial hepatectomy in rats. Gastroenterology 1990;99:771–777.PubMedGoogle Scholar
  11. 11.
    Ohnishi H, Muto Y, Maeda T, et al. Immunological mechanisms of impaired liver regeneration in fulminant hepatic failure (FHF). Hepatology 1991;14(Pt. 2):1 69A.Google Scholar
  12. 12.
    Muto Y, Nouri-Aria KT, Meager A, et al. Enhanced tumor necrosis factor and interleukin-l in fulminant hepatic failure. Lancet 1988;II:72–74.CrossRefGoogle Scholar
  13. 13.
    Liu P, Ohnishi H, Moriwaki H, et al. Enhanced tumor necrosis factor and interleukin-1 in an experimental model of massive hepatic cell necrosis/fatal hepatitis in mice. Gastroenterol Jpn 1990;25: 339–342.PubMedGoogle Scholar
  14. 14.
    Nagaki M, Muto Y, Ohnishi H, et al. Significance of tumor necrosis factor (TNF) and interleukin-1 (IL-1) in the pathogenesis of fulminant hepatitis: Possible involvement of serine protease in TNF-mediated liver injury. Gastroenterol Jpn 1991;26:448–455.PubMedGoogle Scholar
  15. 15.
    Shiratori Y, Moriwaki H, Kawashima Y, et al. Elevated interleukin-6 levels in sera of patients with fulminant hepatitis. Gastroenterol Jpn 1991;26:233.PubMedGoogle Scholar
  16. 16.
    Kawada N, Mizoguchi Y, Kobayashi K, et al. Interferon-γ modulates production of interleukin-1 and tumor necrosis factor by murine Kupffer cells. Liver 1991;ll:24–47.Google Scholar
  17. 17.
    Sakagami Y, Mizoguchi Y, Seki S, et al. Release of peptide leukotrienes from rat Kupffer cells. Biochem Biophy Res Commun 1988;156:217–221.CrossRefGoogle Scholar
  18. 18.
    Shiratori Y, Moriwaki H, Muto Y, et al. Production of leukotriene B4 in parenchymal and sinusoidal cells of the liver in rats treated simultaneously with D-galactosamine and endotoxin. Gastroenterol Jpn 1989;24:640–645.PubMedGoogle Scholar
  19. 19.
    Kawada N, Mizoguchi Y, Shin T, et al. Synthesis of eicosanoids byPropionibacterium acnes-elicited liver adherent cells and their effects on production of interleukin-1 and tumor necrosis factor. Prostaglandins Leukot Essential Fatty Acids 1990;41:187–193.CrossRefGoogle Scholar
  20. 20.
    Chisari FV. Hepatitis B virus cytotoxic T cell response: Characteristics in and consequences in transgenic mice, (presented at International Liver Forum Tokyo ’92, Pathobiology of Hepatitis. Tokyo, April 14, 1992)Google Scholar
  21. 21.
    Chapman RW, Forman D, Peto R, et al. Liver transplantation for acute hepatic failure? Lancet 1990;335:32–35.PubMedCrossRefGoogle Scholar
  22. 22.
    Muto Y. Clinical indication of liver transplantation in fulminant hepatitis. Gastroenterol Jpn 1992;27:429.Google Scholar
  23. 23.
    Takabatake H, Koide N, Tsuji T. Encapsulated multicellular spheroids of rat hepatocytes produce albumin and urea in a spouted bed circulating culture system. Artificial Organs 1991; 15:474–480.PubMedGoogle Scholar
  24. 24.
    Akaike T, Kobayashi A, Kobayashi K, et al. Separation of parenchymal liver cells using a lactose-substituted styrene polymer substratum. J Bioact Compat Polym 1989;4:51–55.CrossRefGoogle Scholar

Copyright information

© The Japanese Society of Gastroenterology 1993

Authors and Affiliations

  • Yasutoshi Muto
    • 1
  1. 1.Research Group of Intractable HepatitisThe Ministry of Health and Welfare of JapanJapan

Personalised recommendations